Buy-rated reports

511 tickers rated Buy
NewestHighest Score Ranks all reports in this rating group by score, highest first.
HubSpot, Inc.
HUBS·Technology
A ★★★★Buy
Current$200.61
Target$248.00
Return+23.6%
Nov 7, 2026

HubSpot combines recurring CRM revenue, improving margins, and AI-driven expansion opportunities with attractive cash-flow valuation, although slowing subscription growth and intensifying AI competition threaten its long-term trajectory.

Score
78
Avient Corporation
AVNT·Materials
A ★★★★Buy
Current$45.50
Target$50.40
Return+10.8%
Nov 7, 2026

Avient offers a reasonably valued specialty-materials earnings recovery supported by stronger organic growth and deleveraging, although cyclical demand, working-capital intensity, and modest capital returns constrain the upside.

Score
78
Pattern Group Inc.
PTRN·Consumer Discretionary
A ★★★★Buy
Current$18.27
Target$21.33
Return+16.7%
Nov 7, 2026

Pattern offers rapid e-commerce growth, strong brand-partner retention, and improving cash generation at a reasonable forward valuation, although Amazon concentration and inventory-intensive economics constrain its moat and profitability.

Score
78
Remitly Global, Inc.
RELY·Technology
A ★★★★Buy
Current$22.32
Target$28.91
Return+29.5%
Nov 7, 2026

Remitly combines durable cross-border payment growth, expanding margins, and strong cash generation with a potentially attractive valuation, although pricing competition, stock-based compensation, and new-product execution remain important risks.

Score
78
Radian Group Inc.
RDN·Financials
A ★★★★Buy
Current$35.97
Target$42.35
Return+17.7%
Nov 7, 2026

Radian combines profitable mortgage insurance, a growing specialty underwriting platform, and substantial shareholder returns at a modest valuation, although catastrophe exposure and acquisition execution remain material risks.

Score
78
Camtek Ltd.
CAMT·Technology
A ★★★★Buy
Current$97.05
Target$121.44
Return+25.1%
Nov 7, 2026

Camtek offers profitable exposure to accelerating advanced-packaging inspection demand and strong 2027 earnings growth, although semiconductor equipment cyclicality, China exposure, and competitive pressure could undermine execution.

Score
78
Itaú Unibanco Holding S.A.
ITUB·Financials
A ★★★★Buy
Current$7.29
Target$8.60
Return+18.0%
Nov 6, 2026

Itaú Unibanco combines a durable Brazilian banking franchise, strong recurring ROE, and attractive earnings multiples, although political uncertainty, currency depreciation, and credit-cycle deterioration could constrain shareholder returns.

Score
78
Healthpeak Properties, Inc.
DOC·Real Estate
A ★★★★Buy
Current$20.17
Target$22.20
Return+10.1%
Nov 5, 2026

Healthpeak offers an attractive healthcare REIT income stream and upside from lab recovery and senior housing growth, although high capital requirements and refinancing sensitivity constrain its valuation upside.

Score
78
Hinge Health, Inc.
HNGE·Healthcare
A ★★★★Buy
Current$120.87
Target$116.71
Return-3.4%
Nov 5, 2026

Hinge Health combines rapid digital healthcare adoption, expanding margins, and exceptional cash generation, but its premium valuation and intensifying competition limit the near-term margin of safety.

Score
78
Realty Income Corporation
O·Real Estate
A ★★★★Buy
Current$59.22
Target$64.40
Return+8.7%
Nov 5, 2026

Realty Income offers dependable monthly dividends backed by diversified long-term leases and accretive acquisitions, although financing costs and equity dilution could limit AFFO-per-share growth.

Score
78
IDEXX Laboratories, Inc.
IDXX·Healthcare
A ★★★★Buy
Current$698.55
Target$653.60
Return-6.4%
Nov 5, 2026

IDEXX combines a deeply integrated veterinary diagnostics ecosystem with exceptional cash generation and recurring revenue growth, but its substantial valuation premium leaves investors exposed to slower testing demand or earnings growth.

Score
78